MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clml.2020.08.028

Медицинская библиотека · Clinical lymphoma, myeloma & leukemia · 2020

Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience.

Kaloyannidis Panayotis, Omari Rawan, Eldebawy Eman, Al Shaibani Eshrak, Apostolidis John, Hindi Taghreed, Raslan Heba, Al Garni Ayed, Al Buali Ahmed, Al Anezi Khalid, Al Hashmi Hani

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with refractory or relapsed lymphoma diagnosed with bulky disease at relapse or with residual disease after salvage treatment are considered to have a dismal outcome, even after autologous hematopoietic stem-cell transplantation, as a result of disease recurrence. To minimize the risk of relapse after receipt of a transplant, involved-field radiotherapy (IFRT) to sites of either bulky or localized residual disease has been utilized; however, the ideal timing for irradiation remains controversial. The aim of this study was to assess the safety and efficacy of IFRT in the early period after transplantation.

PATIENTS AND

METHODS

We retrospectively evaluated the outcome of 24 autografted patients with relapsed/refractory lymphoma who presented with bulky disease at relapse or who had a persistent localized residual mass after salvage treatment and consolidated with IFRT within 4 months after autografting.

RESULTS

No significant toxicity was noticed during the early postradiotherapy period, while graft function was not impaired. After a median follow-up of 3 years for survivors, 21 patients were alive, 19 of whom were event free, while 2 patients died of disease recurrence and 1 died of treatment-related myelodysplastic syndrome. The 3-year overall, lymphoma relapse-free, and event-free survival rates were 86%, 86%, and 82%, respectively.

CONCLUSION

Taking into consideration the poor-risk features of the study cohort, IFRT provided early after autologous hematopoietic stem-cell transplantation showed a safe and well-tolerated toxicity profile and demonstrated long-term effective tumor control, as reflected in the promising survival rates.

Для цитирования: Kaloyannidis Panayotis, Omari Rawan, Eldebawy Eman, Al Shaibani Eshrak, Apostolidis John, Hindi Taghreed, Raslan Heba, Al Garni Ayed, Al Buali Ahmed, Al Anezi Khalid, Al Hashmi Hani. Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience.. Clinical lymphoma, myeloma & leukemia. 2020. DOI: 10.1016/j.clml.2020.08.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.